Shunsuke Nakakura
Osaka University
104 Papers
183 Citations
Shunsuke Nakakura is an academic researcher from Osaka University. The author has contributed to research in topics: Medicine & Intraocular pressure. The author has an hindex of 15, co-authored 76 publications.
Chat about Author
Papers
Relationship between Postoperative Anterior Chamber Depth and Refraction Based on the Haptic Fix Position in Intraocular Lens Intrascleral Fixation
TL;DR: In this article , the authors analyzed the post-operative iris capture tendency regarding the fixation position with respect to the intrascleral fixation (ISF) of intraocular lenses, and calculated the anterior chamber depth (post-op ACD), the estimated ACD when using the SRK/T, and the predicted MRSE.
The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study.
Hideaki Okumichi,Yoshiaki Kiuchi,Tetsuya Baba,Takashi Kanamoto,Tomoko Naito,Shunsuke Nakakura,Hitoshi Tabuchi,Hiroki Nii,Chie Sueoka,Yosuke Sugimoto +9 more
TL;DR: Switching from latanoprost to TTFC in patients with insufficient IOP control has additive IOP-lowering effects, and TTFC is an effective approach for patients receiving latanobrost monotherapy who require more intensive IOP reduction.
Hypotony maculopathy obtained by retro-mode retinal imaging.
TL;DR: Fluorescein angiography, optical coherence tomography, and 3-dimensional magnetic resonance imaging of the eye shows granular hypo-AF surrounded by hyper-AF rim.
4
Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog.
TL;DR: The IOP values and incidence of superficial punctate keratopathy and conjunctival hyperemia were sustained throughout the 24-week observation period, and the patient preferences were similar for the two regimens, however, differences were observed in the ocular sensations of stinging/burning with dorzolamide 1%/timolol 0.5% and blurred vision with brinzol chloride 1% /timoll 0.